This vulnerability affects Oracle Advanced Benefits version 12.2.15 and involves improper access control (CWE-284) that allows a low privileged attacker with network access via HTTP to perform unauthorized modifications to critical data. The vulnerability scope includes potential impact on additional Oracle products beyond Advanced Benefits. The CVSS vector (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:N/I:H/A:N) indicates network attack vector, low attack complexity, low privileges required, no user interaction, scope change, no confidentiality impact, high integrity impact, and no availability impact. Oracle's July 2026 Critical Patch Update advisory lists many patched products but does not explicitly confirm a patch for this version of Oracle Advanced Benefits. Customers are advised to review the advisory and apply patches promptly if available.

Successful exploitation allows unauthorized creation, deletion, or modification of critical data within Oracle Advanced Benefits 12.2.15. The integrity of data can be significantly compromised, potentially affecting additional Oracle products due to scope change. There is no reported impact on confidentiality or availability. No known exploits in the wild have been reported.

Oracle has released a Critical Patch Update advisory in July 2026 covering multiple vulnerabilities across Oracle products. However, the advisory content provided does not explicitly confirm the availability of a patch for Oracle Advanced Benefits 12.2.15 related to CVE-2026-61324. Customers should consult the official Oracle advisory at https://www.oracle.com/security-alerts/cpujul2026.html for the latest patch availability and apply any relevant updates promptly. Until a patch is confirmed and applied, consider restricting network access to Oracle Advanced Benefits interfaces to trusted users only. Patch status is not yet confirmed — check the vendor advisory for current remediation guidance.